Stock Scorer
Stock Board CompareNew Screen
Donate
…
Report Measures Companies
Sign in

Guardian Pharmacy Services, Inc. (GRDN)

Guardian Pharmacy Services, Inc. reported revenue of 351.8M USD for the quarter ending 30 June 2026, up 2.2% from 344.3M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 351.8M +2.2%
Gross Profit Q2 '26 · ending 30 June 2026 80M +17.5%
Operating Income Q2 '26 · ending 30 June 2026 20.6M +64.1%
Net Income Q2 '26 · ending 30 June 2026 21.9M +142.2%
Cost of Revenue Q2 '26 · ending 30 June 2026 271.7M -1.6%
Operating Cash Flow Q2 '26 · ending 30 June 2026 30M +50.6%
Free Cash Flow Q4 '25 · ending 31 December 2025 34.1M —

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 1.4B72.7M49.2M86.8M
20242024-12-31 1.2B-62.9M-110M43.2M

Every period

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-30351.8M
Q1 '262026-03-31336.6M
Q4 '252025-12-31397.6M
Q3 '252025-09-30377.4M
Q2 '252025-06-30344.3M
Q1 '252025-03-31329.3M
Q4 '242024-12-31338.6M
Q3 '242024-09-30314.4M
Q2 '242024-06-30300M
Q1 '242024-03-31275.4M
Q3 '232023-09-30262.7M

Gross Profit Quarterly

PeriodEndingGross Profit
Q2 '262026-06-3080M
Q1 '262026-03-3176.3M
Q4 '252025-12-3185.5M
Q3 '252025-09-3074.7M
Q2 '252025-06-3068.1M
Q1 '252025-03-3164.3M
Q4 '242024-12-3167.1M
Q3 '242024-09-3060.9M
Q2 '242024-06-3061.3M
Q1 '242024-03-3155.1M
Q3 '232023-09-3052.2M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-3020.6M
Q1 '262026-03-3117.7M
Q4 '252025-12-3130.8M
Q3 '252025-09-3016.4M
Q2 '252025-06-3012.6M
Q1 '252025-03-3113M
Q4 '242024-12-3116.8M
Q3 '242024-09-30-104.6M
Q2 '242024-06-3017M
Q1 '242024-03-317.9M
Q3 '232023-09-30-6.3M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-3021.9M
Q1 '262026-03-3113.3M
Q4 '252025-12-3120.9M
Q3 '252025-09-309.8M
Q2 '252025-06-309M
Q1 '252025-03-319.4M
Q4 '242024-12-314.8M
Q3 '242024-09-30-122M
Q2 '242024-06-300
Q1 '242024-03-317.1M
Q3 '232023-09-30-7M

Cost of Revenue Quarterly

PeriodEndingCost of Revenue
Q2 '262026-06-30271.7M
Q1 '262026-03-31260.3M
Q4 '252025-12-31312.1M
Q3 '252025-09-30302.7M
Q2 '252025-06-30276.2M
Q1 '252025-03-31265M
Q4 '242024-12-31271.5M
Q3 '242024-09-30253.5M
Q2 '242024-06-30238.7M
Q1 '242024-03-31220.3M
Q3 '232023-09-30210.5M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-3030M
Q1 '262026-03-316.1M
Q4 '252025-12-3134.6M
Q3 '252025-09-3028.2M
Q2 '252025-06-3019.9M
Q1 '252025-03-3117.6M
Q4 '242024-12-3122.3M
Q3 '242024-09-30-2.2M
Q2 '242024-06-3029.1M
Q1 '242024-03-318.7M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q4 '252025-12-3134.1M
Q3 '252025-09-3024.2M
Q4 '242024-12-3120.1M
Q3 '242024-09-30-4.4M